Emerging treatments for patients with cancer: practical guidelines and expert insights – An ESMO 2017 Industry Satellite Symposium
Dr Antonio González-Martin from the Clinica Universidad de Navarra, Madrid, Spain, introduces the satellite symposium entitled "Emerging treatments for patients with cancer: practical guidelines and expert insights".
Florian Scotté, Medical Oncology and Supportive Care Department, Foch Hospital, Suresnes, France, presents on "The benefits of effective CINV prevention: Reviewing the evidence"
Saroj Vadhan Raj from the UT MD Anderson Cancer Center, Houston, TX, US, presents on "Practical experience with NK-1 receptor antagonists for CINV prevention"
Domenica Lorusso from the Gynaecology Oncology Unit, National Cancer Institute, Milan, Italy discusses “Emerging treatment options for platinum-sensitive ovarian cancer”
Sven Mahner from the Department of Obstetrics and Gynaecology, University Hospital, LMU Munich, Munich, Germany explores the question “Can PARP inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?”
Kathleen Moore from The Stephenson Cancer Center, The University of Oklahoma, Oklahoma City, OK, US discusses “Managing treatment side effects and maintaining quality of life for patients with ovarian cancer”.
Antonio González-Martin, Florian Scotté, Saroj Vadhan Raj, Domenica Lorusso, Sven Mahner and Kathleen Moore discuss emerging treatments for patients with cancer in a panel discussion.
Antonio González-Martin gives a summary of the satellite symposium and closes the session.
Coverage of the satellite symposium session "Emerging treatments for patients with cancer: practical guidelines and expert insights" presented at the European Society for Medical Oncology (ESMO) 2017 Congress on Monday 11 September 2017 in Madrid, Spain.
The symposium was supported by Tesaro, who provided this video coverage.